Nanoemulsion Containing Kojic Dipalmitate and Rosehip Oil: A Promising Formulation to Treat Melasma

Melasma is a hard-to-treat hyperpigmentation disorder. Combined incorporation of kojic dipalmitate (KDP), the esterified form of kojic acid, and rosehip oil, an oil with antioxidant and skin-regenerating properties, into nanocarrier systems appears to be a suitable strategy to develop high-performance formulations. A high-energy method (Ultra-Turrax®) was used to develop nanoemulsions containing up to 2 mg/mL KDP, 5% rosehip oil, and 7.5% surfactant. Formulations were characterized regarding droplet size, size distribution, pH, density, morphology, KDP content, incorporation efficiency, and stability under different temperature conditions. A scale-up study was conducted. Skin permeation, antioxidant potential, and tyrosinase inhibitory activity were assessed in vitro. Cell viability studies were also performed. Results showed that nanoemulsions containing 1 and 2 mg/mL KDP had incorporation efficiencies greater than 95%, droplet size smaller than 130 nm, suitable size distribution, zeta potential of approximately −10 mV, and good stability over 30 days of refrigerated storage. The nanoemulsion containing 1 mg/mL KDP was chosen for further evaluation because it had lower nanocrystal formation, greater scale-up feasibility and allowed KDP permeation up to the epidermis similarly than observed for 2 mg/mL KDP. This formulation (1 mg/mL KDP) showed antioxidant and depigmenting efficacy, close to that of 1 mM ascorbic acid. No cytotoxicity was observed in formulations concentrations ranging from 0.06% to 1%.

[1]  R. V. Contri,et al.  Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis. , 2022, International journal of pharmaceutics.

[2]  N. Akhtar,et al.  Whitening effect of kojic acid dipalmitate loaded nanosized ethosomal gel for the treatment of hyperpigmentation: In vitro and in vivo characterization , 2022, Journal of cosmetic dermatology.

[3]  Siti Efliza Ashari,et al.  In vitro cytotoxicity assay, mushroom tyrosinase inhibitory activity and release analysis of kojic monooleate nanodelivery system and in silico molecular docking study against 2Y9X target enzyme , 2021 .

[4]  Rania M. Hathout,et al.  Enhanced anti-bacterial effect of kojic acid using gelatinized core liposomes: A potential approach to combat antibiotic resistance , 2021 .

[5]  E. Tamizi,et al.  Comparative Stability of Two Anti-hyperpigmentation Agents: Kojic Acid as a Natural Metabolite and Its Di-Palmitate Ester, Under Oxidative Stress; Application to Pharmaceutical Formulation Design , 2021, Advanced pharmaceutical bulletin.

[6]  A. Hedayatizadeh-Omran,et al.  A promising and effective platform for delivering hydrophilic depigmenting agents in the treatment of cutaneous hyperpigmentation: kojic acid nanostructured lipid carrier , 2021, Artificial cells, nanomedicine, and biotechnology.

[7]  K. Andrieux,et al.  Comparison of the In Vitro and Ex Vivo Permeation of Existing Topical Formulations Used in the Treatment of Facial Angiofibroma and Characterization of the Variations Observed , 2020, Pharmaceutics.

[8]  Rosfarizan Mohamad,et al.  An Improved Nanoemulsion Formulation Containing Kojic Monooleate: Optimization, Characterization and In Vitro Studies , 2020, Molecules.

[9]  S. Nanda,et al.  In-vitro Estimation of Photo-Protective Potential of Rosehip Seed Oil and QbD Based Development of a Nanoformulation , 2019, Current Nanomedicine.

[10]  Rowa Al Ramahi,et al.  Depigmentation and anti-aging treatment by natural molecules. , 2019, Current pharmaceutical design.

[11]  M. Saeedi,et al.  Kojic acid applications in cosmetic and pharmaceutical preparations. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  S. Guterres,et al.  Azelaic acid-loaded nanoemulsion with hyaluronic acid – a new strategy to treat hyperpigmentary skin disorders , 2019, Drug development and industrial pharmacy.

[13]  Siti Efliza Ashari,et al.  Development of a kojic monooleate-enriched oil-in-water nanoemulsion as a potential carrier for hyperpigmentation treatment , 2018, International journal of nanomedicine.

[14]  M. Picardo,et al.  Melasma, a photoaging disorder , 2018, Pigment cell & melanoma research.

[15]  V. K. Rai,et al.  Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[16]  M. Roberts,et al.  Topical Nano and Microemulsions for Skin Delivery , 2017, Pharmaceutics.

[17]  H. Greige‐Gerges,et al.  Improvement of skin whitening agents efficiency through encapsulation: Current state of knowledge. , 2017, International journal of pharmaceutics.

[18]  M. Sagrillo,et al.  Evaluation of Stability and In Vitro Security of Nanoemulsions Containing Eucalyptus globulus Oil , 2017, BioMed research international.

[19]  Farooq Ali Khan,et al.  Nanoemulsion: Concepts, development and applications in drug delivery , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Sourav Bhattacharjee,et al.  DLS and zeta potential - What they are and what they are not? , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[21]  S. Guterres,et al.  Nanoencapsulation of Rose-Hip Oil Prevents Oil Oxidation and Allows Obtainment of Gel and Film Topical Formulations , 2016, AAPS PharmSciTech.

[22]  S. Guterres,et al.  Skin penetration and dermal tolerability of acrylic nanocapsules: Influence of the surface charge and a chitosan gel used as vehicle. , 2016, International journal of pharmaceutics.

[23]  Kyoung-Chan Park,et al.  Heterogeneous Pathology of Melasma and Its Clinical Implications , 2016, International journal of molecular sciences.

[24]  C. Mansur,et al.  Development and characterization of promising o/w nanoemulsions containing sweet fennel essential oil and non-ionic sufactants , 2015 .

[25]  Kyung-Min Kwon,et al.  Evaluation of the Antioxidant Activities and Tyrosinase Inhibitory Property from Mycelium Culture Extracts , 2015, Evidence-based complementary and alternative medicine : eCAM.

[26]  M. Chorilli,et al.  Structural Characterization and In Vitro Antioxidant Activity of Kojic Dipalmitate Loaded W/O/W Multiple Emulsions Intended for Skin Disorders , 2015, BioMed research international.

[27]  A. Jindal,et al.  Nanocarriers and nanoparticles for skin care and dermatological treatments , 2013, Indian dermatology online journal.

[28]  S. Guterres,et al.  Vitamin K1–loaded lipid‐core nanocapsules: physicochemical characterization and in vitro skin permeation , 2013, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[29]  S. Guterres,et al.  NANOCÁPSULAS COMO UMA TENDÊNCIA PROMISSORA NA ÁREA COSMÉTICA: A IMENSA POTENCIALIDADE DESTE PEQUENO GRANDE RECURSO , 2013 .

[30]  Arbakariya B. Ariff,et al.  Depigmenting Effect of Kojic Acid Esters in Hyperpigmented B16F1 Melanoma Cells , 2012, Journal of biomedicine & biotechnology.

[31]  S. Baie,et al.  Formulation and stability of whitening VCO-in-water nano-cream. , 2009, International journal of pharmaceutics.

[32]  I. Kamada,et al.  [Treatment of open wounds using Mosqueta Rose: a review]. , 2009, Revista brasileira de enfermagem.

[33]  N. D. da Silveira,et al.  Determining the simultaneous presence of drug nanocrystals in drug-loaded polymeric nanocapsule aqueous suspensions: a relation between light scattering and drug content. , 2008, International journal of pharmaceutics.

[34]  A. Salvador,et al.  A rapid and reliable size-exclusion chromatographic method for determination of kojic dipalmitate in skin-whitening cosmetic products. , 2008, Talanta.

[35]  P. K. Basniwal,et al.  Hydrolytic Degradation Profile and RP-HPLC Estimation of Cilostazol in Tablet Dosage Form , 2008, Indian journal of pharmaceutical sciences.

[36]  M. Pinelo,et al.  Processing of Rosa rubiginosa: extraction of oil and antioxidant substances. , 2007, Bioresource technology.

[37]  Y Martín-Biosca,et al.  Evaluation of the pH effect of formulations on the skin permeability of drugs by biopartitioning micellar chromatography. , 2004, Journal of chromatography. A.

[38]  Franco Lombardo,et al.  Hydrolysis in Pharmaceutical Formulations , 2002, Pharmaceutical development and technology.

[39]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[40]  H. Gautam,et al.  Melanogenesis Inhibitors. , 2018, Acta dermato-venereologica.

[41]  Ruy Carlos Ruver Beck,et al.  Nanocosmetics and nanomedicines , 2011 .

[42]  S. Guterres,et al.  Transport of Substances and Nanoparticles across the Skin and in Vitro Models to Evaluate Skin Permeation and/or Penetration , 2011 .

[43]  S. Baie,et al.  In-vitro and in-vivo evaluation of a photo-protective kojic dipalmitate loaded into nano-creams , 2010 .